Pacific Sage Partners’s AbbVie ABBV Stock Holding History

Pacific Sage Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$291K	Sell	1,158 -20	-2%	-$4.3K	0.04%	101
2026 Q1	$256K	Sell	1,178 -34	-3%	-$7.54K	0.04%	100
2025 Q4	$277K	Buy	1,212 +17	+1%	+$3.87K	0.04%	98
2025 Q3	$277K	Sell	1,195 -2	-0.2%	-$407	0.05%	92
2025 Q2	$222K	Buy	1,197 +42	+4%	+$7.81K	0.04%	103
2025 Q1	$242K	Sell	1,155 -25	-2%	-$4.86K	0.05%	86
2024 Q4	$210K	Hold	1,180	–	–	0.05%	96
2024 Q3	$233K	Sell	1,180 -86	-7%	-$16.1K	0.06%	85
2024 Q2	$217K	Buy	1,266 +13	+1%	+$2.15K	0.05%	89
2024 Q1	$228K	Buy	+1,253	New	+$216K	0.06%	83
2023 Q2	–	Sell	-1,284	Closed	-$205K	–	91
2023 Q1	$205K	Sell	1,284 -125	-9%	-$19.1K	0.07%	80
2022 Q4	$228K	Buy	+1,409	New	+$216K	0.08%	71

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pacific Sage Partners's ABBV Position: Q2 2026 in Review

Pacific Sage Partners reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $4.3K and leaving 1,158 shares worth $291K. The position accounts for 0.04% of the portfolio, ranked #101.

Pacific Sage Partners first reported a position in ABBV in Q4 2022 and has held it in 12 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pacific Sage Partners held 1,158 shares of AbbVie worth $291K as of Q2 2026.
Pacific Sage Partners sold 20 AbbVie shares in Q2 2026, an estimated $4.3K.
AbbVie made up 0.04% of Pacific Sage Partners's portfolio in Q2 2026, its #101 holding.
Pacific Sage Partners first reported a position in AbbVie in Q4 2022 and has held it in 12 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pacific Sage Partners's 13F filing for Q2 2026, filed 6 Aug 2026.